Guatemala vs Lithuania: Treatment success rate for patients treated for MDR-TB
Guatemala
70.0%
in 2022
Lithuania
70.0%
in 2022
Guatemala rank
96th
Lithuania rank
96th
Treatment success rate for patients treated for MDR-TB over time
- Guatemala
- Lithuania
How they compare
Guatemala currently reports 70.0% against 70.0% in Lithuania, a difference of 0.0%.
The two have swapped places 2 times across 16 shared years of data; in 2007 it was Lithuania ahead.
Guatemala ranks 96th and Lithuania ranks 96th of 163 countries.
Across the 3 decades both report, Guatemala averaged higher in 2 and Lithuania in 1.
Head to head by decade
| Decade | Guatemala | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.7% | 19.7% | 3.0% | Guatemala |
| 2010s | 59.5% | 47.7% | 11.8% | Guatemala |
| 2020s | 63.3% | 68.3% | 5.0% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Guatemala or Lithuania?
- Guatemala, at 70.0% against 70.0% in Lithuania as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Guatemala and Lithuania?
- 0.0%, with Guatemala ahead.
- How many years of comparable data are there for Guatemala and Lithuania?
- 16 years are reported by both, from 2007 to 2022.
- How do Guatemala and Lithuania rank globally for treatment success rate for patients treated for mdr-tb?
- Guatemala ranks 96th and Lithuania ranks 96th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.